Adult-Onset Still's Disease With Severe Hyperferritinemia and the Asian Salmon-Pink Rash: A Case Report
- PMID: 35911342
- PMCID: PMC9312864
- DOI: 10.7759/cureus.26257
Adult-Onset Still's Disease With Severe Hyperferritinemia and the Asian Salmon-Pink Rash: A Case Report
Abstract
Adult-onset Still's disease (AOSD) is a systemic inflammatory disease characterized by rash, arthritis, and persistent spiking fever. The diagnosis and treatment of AOSD are challenging due to the lack of specific diagnostic criteria and little evidence of effective treatments. Here, we reported a case of an 18-year-old woman with a fever of unknown origin (FUO), evanescent rash (without the typical "salmon-pink" color), and systemic lymphadenopathy. Laboratory tests at hospital admission revealed marked hyperferritinemia of 12,100 ng/mL. AOSD was subsequently suspected. Additional anti-nuclear-antibody analysis for differential diagnosis was negative. The initiation treatment with high-dose prednisolone, tapered to half every week, was immediately started. The symptoms temporarily improved but relapsed during the tapering period. The prednisolone dose was increased again, and tocilizumab was introduced. Symptom remission and prednisolone dose reduction were subsequently achieved. Therefore, a medication tapering schedule and treatment replacement to inhibit the pathophysiology of AOSD need to be carefully considered. While a ferritin test is useful to diagnose AOSD based on the presence of FUO, there are AOSD patients without hyperferritinemia. Additionally, AOSD rash on Asian skin may not present with the typical "salmon-pink" color.
Keywords: adult-onset still’s disease; fever of unknown origin; general medicine; hyperferritinemia; relapse; rural hospital; salmon-pink rash; steroid tapering; tocilizumab.
Copyright © 2022, Fukunaga et al.
Conflict of interest statement
The authors have declared that no competing interests exist.
Figures
Similar articles
-
Urticarial rash, fever, and arthritis: A case of refractory Adult-onset Still's disease with good response to tocilizumab.Dermatol Ther. 2019 Sep;32(5):e13041. doi: 10.1111/dth.13041. Epub 2019 Aug 12. Dermatol Ther. 2019. PMID: 31361930 Review.
-
Adult-onset Still's disease and fever of unknown origin in India.Clin Exp Med. 2023 Sep;23(5):1659-1666. doi: 10.1007/s10238-022-00903-3. Epub 2022 Sep 30. Clin Exp Med. 2023. PMID: 36178600 Free PMC article.
-
Adding colchicine to immunosuppressive treatments; a potential option for biologics-refractory adult-onset Still's disease.BMC Res Notes. 2018 May 21;11(1):320. doi: 10.1186/s13104-018-3420-8. BMC Res Notes. 2018. PMID: 29784018 Free PMC article.
-
Sore Throat to Still's: Group A Streptococcus Causing Adult-Onset Still's Disease.Cureus. 2024 Sep 11;16(9):e69201. doi: 10.7759/cureus.69201. eCollection 2024 Sep. Cureus. 2024. PMID: 39398785 Free PMC article.
-
Interleukin-18 as a diagnostic marker of adult-onset Still's disease in older patients: a case report and review of the literature.J Med Case Rep. 2018 Jul 10;12(1):198. doi: 10.1186/s13256-018-1735-7. J Med Case Rep. 2018. PMID: 29986752 Free PMC article. Review.
Cited by
-
Not All Fevers Equal Infection: A Challenging Case of Adult-Onset Still's Disease.Cureus. 2024 May 9;16(5):e59968. doi: 10.7759/cureus.59968. eCollection 2024 May. Cureus. 2024. PMID: 38854353 Free PMC article.
-
Atypical Adult Still's Disease Complicated by Hemophagocytic Syndrome in an Older Patient: A Case Report.Cureus. 2023 Oct 12;15(10):e46922. doi: 10.7759/cureus.46922. eCollection 2023 Oct. Cureus. 2023. PMID: 38021678 Free PMC article.
-
Long-Term Health Consequences of SARS-CoV-2- Trigger for Still Disease in Adults.ACR Open Rheumatol. 2025 Apr;7(4):e70042. doi: 10.1002/acr2.70042. ACR Open Rheumatol. 2025. PMID: 40264248 Free PMC article.
-
A Case of Suspected T-cell Intravascular Lymphoma Mimicking Multiple Hepatic Abscesses and Adult-Onset Still's Disease.Cureus. 2023 Oct 23;15(10):e47534. doi: 10.7759/cureus.47534. eCollection 2023 Oct. Cureus. 2023. PMID: 38021999 Free PMC article.
References
-
- Autoinflammatory pathogenesis and targeted therapy for adult-onset Still's disease. Li S, Zheng S, Tang S, Pan Y, Zhang S, Fang H, Qiao J. Clin Rev Allergy Immunol. 2020;58:71–81. - PubMed
-
- Efficacy of traditional and biologic agents in different clinical phenotypes of adult-onset Still's disease. Franchini S, Dagna L, Salvo F, Aiello P, Baldissera E, Sabbadini MG. Arthritis Rheum. 2010;62:2530–2535. - PubMed
Publication types
LinkOut - more resources
Full Text Sources